Compounds > sulfosuccinimidyl 6-((4-azido-2-nitrophenyl)amino)hexanoate

Page last updated: 2024-12-10

sulfosuccinimidyl 6-((4-azido-2-nitrophenyl)amino)hexanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sulfosuccinimidyl 6-((4-azido-2-nitrophenyl)amino)hexanoate: cross-links beta-bungarotoxinto chick brain membranes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	3035866
SCHEMBL ID	13490789
MeSH ID	M0172559

Synonyms (18)

Synonym
ssanpah
1-[6-(4-azido-2-nitroanilino)hexanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid
sulfosuccinimidyl 6-((4-azido-2-nitrophenyl)amino)hexanoate
102568-43-4
1-((6-((4-azido-2-nitrophenyl)amino)-1-oxohexyl)oxy)-2,5-dioxo-3-pyrrolidinesulfonic acid
sulfo-sanpah
sulfosuccinimidyl 6-(4'-azido-2'-nitrophenylamino)hexanoate
sulfo sanpah
3-pyrrolidinesulfonic acid, 1-((6-((4-azido-2-nitrophenyl)amino)-1-oxohexyl)oxy)-2,5-dioxo-
SCHEMBL13490789
sulfo-sanpah crosslinker
sulfo-succinimidyl-6-[(4'-azido-nitrophenyl)amino]hexanoate
sulphosuccinimidyl 6-(4'-azido-2'-nitrophenylamino)hexanoate
hexanoic acid, 6-[(4-azido-2-nitrophenyl)amino]-, 2,5-dioxo-3-sulfo-1-pyrrolidinyl ester
DTXSID20907709
1-{[6-(4-azido-2-nitroanilino)hexanoyl]oxy}-2,5-dioxopyrrolidine-3-sulfonic acid
mfcd00054986
AKOS040754112

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	1 (14.29)	18.7374
1990's	2 (28.57)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.51 (24.57)
Research Supply Index	2.08 (2.92)
Research Growth Index	4.59 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	7 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
aminocaproic acid Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.. 6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.	2.08	1	0	amino acid zwitterion; epsilon-amino acid; omega-amino fatty acid	antifibrinolytic drug; hematologic agent; metabolite
dapi DAPI: RN given refers to parent cpd.	2.04	1	0	indoles	fluorochrome
tyrosine Tyrosine: A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.. tyrosine : An alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring.	1.97	1	0	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine	EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
ethyldimethylaminopropyl carbodiimide Ethyldimethylaminopropyl Carbodiimide: Carbodiimide cross-linking reagent.	2.38	2	0
azides Azides: Organic or inorganic compounds that contain the -N3 group.. azide : Any nitrogen molecular entity containing the group -N3.	3.39	7	0	pseudohalide anion	mitochondrial respiratory-chain inhibitor
hydroxysuccinimidyl-4-azidobenzoate N-(4-azidobenzoyloxy)succinimide: structure in first source	1.97	1	0
bis(sulfosuccinimidyl)suberate bis(sulfosuccinimidyl)suberate: structure given in first source	1.97	1	0
carbodiimides Carbodiimides: Compounds with the general formula RN=C=NR, where R is a hydrocarbyl group.. methanediimine : A carbodiimide in which both nitrogens are unsubstituted.	2.03	1	0	carbodiimide
polidocanol Polidocanol: An alkyl polyglycol ether of LAURYL ALCOHOL, chemically defined as an alcohol ethoxylate having an average alkyl chain of 12–14 carbon atoms, and an ethylene oxide chain of 9 ethylene oxide units. It is used as a detergent, and medically as a local anesthetic, and as a sclerosing agent for the treatment of ESOPHAGEAL AND GASTRIC VARICES and VARICOSE VEINS.. polidocanol : A hydroxypolyether that is nonaethylene glycol in which one of the terminal hydroxy functions is substituted by a lauryl (dodecyl) group.	1.97	1	0	hydroxypolyether	hepatotoxic agent; nonionic surfactant; sclerotherapy agent
tetramethylrhodamine isothiocyanate tetramethylrhodamine isothiocyanate: used for labeling of antibodies with fluorochromes; easily dissolved with DMSO; conjugates with immunoglobulins	2.04	1	0
1-hydroxyvitamin d5 1-hydroxyvitamin D5: structure given in first source	2.02	1	0
sepharose agarose : A linear polysaccharide made up from alternating D-galactose and 3,6-anhydro-alpha-L-galactopyranose residues joined by alpha-(1->3)- and beta-(1->4)-linkages.	1.97	1	0
mast cell degranulating peptide mast cell degranulating peptide: isolated from bee venoms; made up of 22 amino acids; has 2 disulfide bridges	1.97	1	0
epidermal growth factor Epidermal Growth Factor: A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form.	2.04	1	0
caseins Caseins: A mixture of related phosphoproteins occurring in milk and cheese. The group is characterized as one of the most nutritive milk proteins, containing all of the common amino acids and rich in the essential ones.	2.02	1	0